Search

everythinglearnresearchcommunity

for

Search:↓

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

The microbiome may be linked to hair loss and could be a target for new treatments.

Wound healing is greatly affected by the types of bacteria present, which can either help or hinder the process.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

The scalp's microorganisms significantly affect hair health and disease.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

Ostrich antibodies are a promising, cost-effective treatment for various skin diseases and conditions.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Asylum seekers arriving by boat may face skin problems due to harsh conditions, and doctors should use a thorough skin assessment approach to diagnose and treat them effectively.

Cats lose fur due to various reasons, including allergies, infections, genetics, hormones, diet, cancer, stress, and some conditions are treatable while others are not.